Trial Profile
Gemcitabine plus carboplatin in patients with pretreated metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Gemcitabine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 25 May 2007 New trial record.